Registration
ARNOLD & PORTER KAYE SCHOLER LLP for SPYRE THERAPEUTICS, INC.
Client
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
FDA policies relating to monoclonal antibody products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BOBBY MCMILLIN New | General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007) |
Pharmacy PHA
FDA policies relating to monoclonal antibody products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BOBBY MCMILLIN New | General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007) |
Health Issues HCR
FDA policies relating to monoclonal antibody products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BOBBY MCMILLIN New | General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.